SEARCH HEALTH CONDITIONS BY ALPHABETS
Microscopic Polyangiitis
Medications for Microscopic polyangiitis
Other titles: MPA
About Microscopic polyangiitis: Microscopic polyangiitis (MPA) is an inflammation of this medium and compact vessel walls that could affect unique areas of your human body for example (but not limited to) the kidneys, lungs, sinuses, nerves and skin.
Drugs Used to Treat Microscopic polyangiitis
The following listing of medications are in some way associated with, or used in the treating this particular condition.
Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Rituxan | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: rituximab systemic Medicine class: Anti-rheumatics, CD20 monoclonal antibodies For customers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
rituximab | Rx | C | N | 1 inspection | 2.0 | ||
Generic name: rituximab systemic Brand name: Rituxan Medicine class: Anti-rheumatics, CD20 monoclonal antibodies For customers: dosage, interactions, For professionals: az Drug Truth, AHFS DI Monograph | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Off Label | This drug might not be accepted by the FDA for treating this particular condition. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal research studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in pregnant women clearly outweigh potential rewards. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | isn`t at the mercy of the Controlled Substances Act. |
1 | includes a high potential for misuse. Has no currently accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
2 | includes a high potential for misuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe physical or psychological dependence. |
3 | features a potential for abuse less than individuals in schedules 1 and two. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | includes a low potential for abuse in accordance with individuals in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
5 | includes a low potential for abuse in accordance with individuals in schedule 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always consult with your healthcare provider to ensure the information displayed on this page pertains to your circumstances.